Previewing biopharma trends ahead of #BIO22; Looking back at #ASCO22; Smooth flight for bluebird?; and more 

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.

With ASCO behind us and BIO just ahead, we’re feeling the heat of the biotech summer. Many of my colleagues will be in San Diego next week. Safe travels to everyone making the trip there.

CONTAINS PAYWALL #BIO22 special

Endpoints News will be hosting our first in-person events at BIO in two years, and we have a full slate of panels lined up to discuss biopharma at the crossroads. Setting the stage, Endpoints founder John Carroll chatted with BIO chair Paul Hastings, polled the E100 group of biotech CEOs for their sentiments as well as views…
Click here to view original post